Search Results 851-860 of 16902 for IUD

  1. A Study of the Combination of IMCgp100 with Durvalumab and/or Tremelimumab for Patients with Advanced Cutaneous Melanoma - Mayo Clinic

    Placement of an intrauterine device or intrauterine system; Use of oral, injected, or implanted hormonal methods of contraception or other forms of hormonal ...

  2. Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure - Mayo Clinic

    ... intrauterine device, a double-barrier method [such as condom plus diaphragm with spermicide], a progesterone-only contraceptive implant/injection, or have a ...

  3. Mayo Clinic

    See also · Abdominal aortic aneurysm · Acne · Actinic keratosis · Atrial septal defect (ASD) · Autoimmune pancreatitis · Back pain · Benign paroxysmal positional ...

  4. Mayo Clinic

    See also · Abdominal aortic aneurysm · Acne · Actinic keratosis · Atrial septal defect (ASD) · Autoimmune pancreatitis · Back pain · Benign paroxysmal positional ...

  5. Mayo Clinic

    Share · Tweet. See also. Abdominal aortic aneurysm · Acne · Actinic keratosis · Atrial septal defect (ASD) · Autoimmune pancreatitis · Back pain ...

  6. Robotic surgery - Doctors & Departments - Mayo Clinic

    ... Intrauterine device method, Vulvectomy, Ovarian remnant removal, Hyperthermic intraperitoneal chemotherapy, Loop electrosurgical excision procedure, Pelvic ...

  7. A Study to Evaluate the Effectiveness and Safety of DA-1229 (Evogliptin) in Delaying Progression of Mild or Moderate Calcific Aortic Stenosis (EVOID-AS trial) - Mayo Clinic

    ... intrauterine device (IUD), or if the female subject/partner is surgically sterile or 2 years post-menopausal. All male subjects/partners of WOCBP must agree ...

  8. Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome - Mayo Clinic

    Use of intrauterine device (placed more than 3 months before randomization). Injectable combined hormonal or contraceptive medication implant alone ...

  9. A Study to Evaluate APG2575 Combined with Novel Therapeutic Regimens To Treat Subjects with Relapsed or Refractory Multiple Myeloma and Immunoglobulin Light Chain Amyloidosis - Mayo Clinic

    ... [IUDs], sexual abstinence, or sterilized partner) during the period of therapy and for 90 days after the last dose of study drug. Ability to complete ...

  10. Pembrolizumab and Ibrutinib in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery - Mayo Clinic

    ... intrauterine device, diaphragm with spermicide, cervical cap with spermicide, male condoms, or female condom with spermicide) or prior surgical ...